Advertisements


Valeant Pharmaceuticals: Intrigued…Really?

Deutsche Bank analyst Gregg Gilbert is warming up the the controversial drug maker. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

Valeant Pharmaceuticals International Breaks Above 200-Day Moving Average - Bullish for VRX.CA

Canada Stock Channel.....»»

Category: topSource: redinewsJun 23rd, 2017

Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?

InvestorPlace - Stock Market News, Stock Advice.....»»

Category: topSource: investorplaceJun 22nd, 2017

Valeant Pharmaceuticals Will Rally On These 3 Near-Term Catalysts

Valeant Pharmaceuticals Will Rally On These 3 Near-Term Catalysts.....»»

Category: topSource: seekingalphaJun 20th, 2017

Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»

Category: topSource: investorplaceJun 19th, 2017

Billionaire investor Paulson joins Valeant board, shares jump

(Reuters) - Billionaire investor John Paulson, whose hedge fund firm is the biggest owner of Valeant Pharmaceuticals International Inc shares, on Monday joined the ailing drug company's board as it restructures to repay debt......»»

Category: topSource: reutersJun 19th, 2017

Valeant"s largest shareholder John Paulson joins board

(Reuters) - Activist investor and hedge fund manager John Paulson has joined Valeant Pharmaceuticals International Inc's board, a move that comes at a time when the embattled Canadian drugmaker is restructuring itself to repay debt......»»

Category: topSource: reutersJun 19th, 2017

You Say Valeant Pharmaceuticals Share Is Still Worth US$200? – Anchoring

How to recognize anchoring What would be the reason for someone to think that a Valeant Pharmac.....»»

Category: blogSource: valuewalkJun 19th, 2017

Valeant"s stock surges after largest shareholder John Paulson elected to board

Shares of Valeant Pharmaceuticals International Inc. surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson's h.....»»

Category: topSource: marketwatchJun 19th, 2017

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Great Speculative Value

InvestorPlace - Stock M.....»»

Category: topSource: investorplaceJun 15th, 2017

Valeant (VRX) Down 4% Since Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Valeant Pharmaceuticals International, Inc. VRX. Shares have lost about 4% in that time frame, underperforming the market. read more.....»»

Category: blogSource: benzingaJun 14th, 2017

Valeant (VRX) Down 4% Since Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Valeant Pharmaceuticals International, Inc. VRX. Shares have lost about 4% in that time frame, underperforming the market. read more.....»»

Category: blogSource: benzingaJun 14th, 2017

Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M

Valeant Pharmaceuticals International, Inc. VRX announced that it has signed a deal to sell iNova Pharmaceuticals for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group. read more.....»»

Category: blogSource: benzingaJun 12th, 2017

Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M

Valeant Pharmaceuticals International, Inc. (VRX) announced that it has signed a deal to sell iNova Pharmaceuticals for .....»»

Category: topSource: zacksJun 12th, 2017

Valeant Pharmaceuticals International, Inc. (VRX) Stock Is Still Too Ugly

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Va.....»»

Category: topSource: investorplaceJun 11th, 2017

UPDATE: Valeant Pharmaceuticals: Almost There?

Valeant Pharmaceuticals said it would sell one of its units today and use part of the proceeds to pay down its debt......»»

Category: blogSource: barronsJun 8th, 2017

Valeant Pharmaceuticals: Bigger is Better

Though the sale of its iNova unit brings Valeant Pharmaceuticals close to meeting its goal of $5 billion in debt reduction by February 2018, the drug maker may need to step up its deal making if it wants to take a real bite out of its debt load......»»

Category: blogSource: barronsJun 8th, 2017

Don’t Buy the Valeant Pharmaceuticals Intl Inc (VRX) Stock Hype

InvestorPlace - Stock Market News, Stock Advice & Trading Tips V.....»»

Category: topSource: investorplaceJun 8th, 2017

Valeant looks to trim debt pile with $930 million iNova sale - Reuters

ReutersValeant looks to trim debt pile with $930 million iNova saleReutersThe company logo of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19,.....»»

Category: topSource: googlenewsJun 8th, 2017

Valeant Pharmaceuticals Plans to Sell iNova Segment

Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business......»»

Category: blogSource: 247wallstJun 8th, 2017

Valeant Pharmaceuticals: Almost There?

Valeant Pharmaceuticals said it would sell one of its units today and use part of the proceeds to pay down its debt......»»

Category: blogSource: barronsJun 8th, 2017